Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the company and its research collaborators will present 25 abstracts—including five rapid oral ...
Dr. Roach weighs in on whether a patient should proceed with a prostate biopsy after conflicting test results.
A doctor advises a 68-year-old patient with a high 4Kscore result to proceed with a prostate biopsy despite a low-risk MRI.
A physician advises a 68-year-old patient with a high 4Kscore result to consider a prostate biopsy despite being on warfarin, ...
1d
Dear Doctor: There's a 49% chance of aggressive prostate cancer, but my doctor is hesitant to biopsy
A conflicting MRI result and the complications of blood thinner use have left one 68-year-old man and his physician at a crossroads.
I am 68 years old and have an enlarged prostate and benign prostatic hyperplasia (BPH). I’ve been taking tamsulosin for about ...
1d
Dear Doctor: My physician says my prostate cancer risk is nearly 50%, but a biopsy comes with risks
However, I think there are a number of other tests that could be done, such as a Prostate Health Index (phi) test or perhaps others. Would I benefit from taking a different test, or should we stick ...
IF GETTING A screening test for prostate cancer isn’t on your radar, it’s probably because the government guidelines ...
Since there were no particular issues with the pre-admission tests, it was decided that I would undergo a prostate biopsy ...
Prostate cancer patients are benefitting from a machine that delivers radiotherapy treatment faster. The radiotherapy team at ...
(NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) today announced that five abstracts presented at the 15th Interventional MRI (“iMRI”) Symposium in Boston, Massachusetts, reinforce the growing ...
A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results